Trademarkia Logo

Canada

C$
Trademark Search in Canada
GALAPAGOS DESIGN (BLACK&GREY)

View On IC.GC.CA

GALAPAGOS DESIGN (BLACK&GREY)
REGISTERED

on 5 Nov 2021

Last Applicant/ Owned by

GALAPAGOS N.V.

Generaal de Wittelaan L11 A3BE-2800 Mechelen

BE

Serial Number

1917465 filed on 30th Aug 2018

Registration Number

TMA1113384 registered on 5th Nov 2021

Registration expiry Date

5th Nov 2031

Correspondent Address

METHOD LAW PROFESSIONAL CORPORATION

4211 Yonge StreetSuite 310Toronto

ONTARIO

CA

M2P2A9

GALAPAGOS DESIGN (BLACK&GREY)

Trademark usage description

pharmaceutical substances and preparations for human use namely, for the treatment of bone cartilage and joint disease, auto inflammation diseases, au Read More

Vienna Information

3 . 9 . 1

Fish, animals of fish-like formPoissons, animaux ayant la forme de poissons

3 . 9 . 24

Animals of division 3.9 stylizedAnimaux de la division 3.9 stylisés

25 . 5 . 1

Backgrounds divided into two, verticallyFonds partagés en deux dans le sens vertical

26 . 4 . 2

RectanglesRectangles

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 15

Quadrilaterals containing representations of animals or parts of animals' bodies or plantsQuadrilatères contenant la représentation d'animaux, de parties du corps d'un animal ou de végétaux

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

Classification Information

Class [005]
Pharmaceutical substances and preparations for human use namely, for the treatment of bone cartilage and joint disease, auto inflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes; bio pharmaceutical substances and preparations for human use, namely, for the treatment of bone cartilage and joint disease, auto inflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes

Classification kind code

11

Class [040]
Manufacturing and assembly of pharmaceuticals for others

Classification kind code

11

Class [042]
Medical research services; biomedical research services pharmaceutical research and development in the field of assay development, target discovery and validation, drug development, and medicinal chemistry; pharmaceutical; pharmaceutical and biopharmaceutical research and development services; scientific research in the field of genetics and genetic engineering; development, examination and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, examination and testing of medicaments; the development of test systems for pharmaceutical and biopharmaceutical products namely, for the treatment of bone cartilage and joint disease, auto inflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes;development of databases in the medical, pharmaceutical and biopharmaceutical field and development of gene banks

Classification kind code

11

Class [044]
Medical clinic services and medical testing services; medical and pharmaceutical advisory and consultancy services relating to the treatment of and pharmaceuticals for the treatment of bone cartilage and joint disease, auto inflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes; manufacturing and assembly of pharmaceuticals for others

Classification kind code

11

Mark Details

Serial Number

1917465

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 27th Oct 2021		Registration Pending
Submitted for opposition 42
on 4th Aug 2021		Advertised
Submitted for opposition 26
on 7th Jul 2021		Approved
Submitted for opposition 27
on 7th Jul 2021		Approval Notice Sent
Submitted for opposition 48
on 13th May 2021		Agent Changed
Submitted for opposition 22
on 14th Oct 2020		Search Recorded
Submitted for opposition 20
on 14th Oct 2020		Examiner's First Report
Submitted for opposition 31
on 5th Sept 2018		Formalized
Submitted for opposition 30
on 30th Aug 2018		Filed
Submitted for opposition 1
on 30th Aug 2018		Created